Clinical trials: Proliferative Diabetic Retinopathy (PDR), open to volunteers
Proliferative Diabetic Retinopathy (PDR)
Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy
The goal of this clinical trial is to learn whether early microincision vitrectomy surgery (MIVS) can improve retinal neovascularization outcomes compared to standard pan-retinal photocoagulation (PRP) in patients with early…
- Trial name
- NCT07586787
- Testing
- Microincision Vitrectomy Surgery, Panretinal Photocoagulation
- Where
- 6 sites in China
- Volunteers
- 100 people
- Sponsor
- Xiamen Ophthalmology Center Affiliated to Xiamen University
PDR - Proliferative Diabetic Retinopathy
The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)
This study aims to slow down disease progression, reduce postoperative complications and decrease retreatment frequency in subjects with proliferative diabetic retinopathy (PDR) by administering a single subretinal injection of…
- Trial name
- NCT06412224
- Testing
- RRG001
- Where
- China
- Volunteers
- 6 people
- Sponsor
- Li Xiaorong
Proliferative Diabetic Retinopathy (PDR)
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
This randomized trial will compare treatment strategies for proliferative diabetic retinopathy (PDR). Participants will receive either combination a of faricimab + PRP or vitrectomy + endolaser.
- Trial name
- AP (NCT06790784)
- Testing
- Vitrectomy, Endolaser, Faricimab
- Where
- 34 sites in United States
- Volunteers
- 426 people
- Sponsor
- Jaeb Center for Health Research
Proliferative Diabetic Retinopathy, Photocoagulation Burn to Retina
New Pattern of Retinal Laser Treatment for PDR
The objective of the study is to evaluate the efficacy of a new pattern of argon-laser in treating patients with proliferative diabetic retinopathy (PDR).
- Trial name
- NCT07315802
- Testing
- A new pattern of retinal laser
- Where
- China
- Volunteers
- 300 people
- Sponsor
- Eye & ENT Hospital of Fudan University
Proliferative Diabetic Retinopathy (PDR)
To Investigate the Feasibility and Acceptability of Trained Non-medical Professionals Performing Laser Treatment for Proliferative Diabetic Retinopathy (PDR), and the Potential Impact on Service Capacity. Assess Feasibility of Conducting a Full Trial Comparing Trained ECPs With Ophthalmologists
To Investigate the Feasibility and Acceptability of Trained Non-medical Professionals Performing Laser Treatment for Proliferative Diabetic Retinopathy (PDR), and the Potential Impact on Service Capacity.
- Trial name
- Avenue-PDR (NCT07923292)
- Testing
- Trained non-medical professionals (eye care practitioners (ECPs)) performing laser treatment for proliferative diabetic retinopathy (PDR), and the potential impact on service capacity
- Where
- United Kingdom
- Volunteers
- 50 people
- Sponsor
- Swansea Bay University Health Board